Karizoo Noroclav® LC Laboratories launches for the treatment of mastitis in lactating cattle
It contains a combination of amoxicillin, clavulanic acid and prednisolone that acts synergistically to provide a combination of broad-spectrum antibacterial activity, Staphylococci (including strains producing β-lactamase), Streptococci (including S. agalactiae, S. dysgalactiae and S. uberis), Escherichia coli (including β-lactamase-producing strains) and anti-inflammatory action that helps reduce the swelling and inflammation associated with bovine mastitis.
Noroclav® LC is a therapy of 3 treatments, every 12 h,
It is available in a pack of 24 syringes of 3 g each, which allows 8 complete treatments.
Withdrawal periods of 84 hours in milk and 7 days in meat.
